Amalgamated Bank Has $7.71 Million Holdings in Humana Inc. (NYSE:HUM)

Amalgamated Bank lessened its position in shares of Humana Inc. (NYSE:HUM) by 0.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,351 shares of the insurance provider’s stock after selling 75 shares during the period. Amalgamated Bank’s holdings in Humana were worth $7,713,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mendota Financial Group LLC increased its position in Humana by 9.2% during the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after buying an additional 27 shares during the period. Capital Advisors Ltd. LLC increased its position in Humana by 17.0% during the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after acquiring an additional 31 shares during the period. CarsonAllaria Wealth Management Ltd. raised its stake in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Harbour Investments Inc. raised its stake in Humana by 10.5% in the 2nd quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after purchasing an additional 41 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft boosted its holdings in Humana by 1.0% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock valued at $1,649,000 after purchasing an additional 42 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Truist Financial cut their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Royal Bank of Canada lowered their target price on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, Stephens reissued an “equal weight” rating and set a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Price Performance

Humana stock opened at $288.69 on Thursday. The stock has a market capitalization of $34.76 billion, a price-to-earnings ratio of 25.57, a PEG ratio of 1.98 and a beta of 0.52. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s 50 day moving average price is $291.98 and its two-hundred day moving average price is $333.24.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, equities analysts predict that Humana Inc. will post 16.15 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.